# Niagen Bioscience outlines plans for 5,000-participant, 3-year Mass General Brigham trial as it targets early 2027 NR malate commercialization

- Source: Seeking Alpha Market Currents
- Published: 2026-11-05T06:45:31+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4666217-niagen-bioscience-outlines-plans-for-5000-participant-3-year-mass-general-brigham-trial-as-it?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/niagen-bioscience-outlines-plans-for-5-000-participant-3-year-mass-gen-84f2cd/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._